50 Participants Needed

Time-Restricted Eating for Cancer-Related Fatigue

AK
Overseen ByAmber Kleckner, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Maryland, Baltimore
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will assess the feasibility of delivering a 12-week time-restricted eating intervention as well as the intervention's preliminary efficacy on persistent cancer-related fatigue among cancer survivors compared to a general health education control. Participants will be randomized 1:1 to one of two arms: time-restricted eating or control. Those in the intervention arm will self-select a 10-hour eating window in which to consume all food and beverages (water is allowed any time, black coffee and unsweetened tea are allowed in the morning). Both groups will receive weekly educational tips on healthy lifestyle behaviors in cancer survivorship. This study will also explore relationships between fatigue, circadian rhythm, and glucose metabolism. The hypothesis is that recruitment will be feasible, and participants will adhere to time-restricted eating and complete study activities over the course of the 12 weeks. The second hypothesis is that time-restricted eating will lead to less fatigue at 12 weeks compared to the control, accounting for baseline fatigue levels.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are taking insulin or have any contraindications to the nutrition intervention, you may not be eligible to participate.

What data supports the effectiveness of the treatment Time-Restricted Eating for Cancer-Related Fatigue?

Research suggests that time-restricted eating (TRE) can improve metabolic health and reduce body weight, which may indirectly help with cancer-related fatigue. Although direct evidence in humans is limited, studies in animals show beneficial effects on energy metabolism and overall health.12345

Is time-restricted eating safe for humans?

Time-restricted eating (TRE) has been studied in humans and generally appears safe, with some studies showing benefits like weight loss and improved cardiometabolic health. However, results can vary, and more research is needed to fully understand its effects across different populations.12367

How is time-restricted eating different from other treatments for cancer-related fatigue?

Time-restricted eating (TRE) is unique because it focuses on limiting food intake to specific hours of the day, aligning with the body's natural circadian rhythms, which may help improve energy metabolism and reduce fatigue. Unlike other treatments that might involve medication or supplements, TRE is a dietary approach that leverages the timing of meals to potentially alleviate cancer-related fatigue.25689

Eligibility Criteria

This trial is for cancer survivors who are at least 18 years old, have completed their main treatments between 2 months and 2 years ago, can use a smartphone, speak English, and consent to study procedures. They must feel fatigued (score of 4+ on a scale of 0-10) but not be underweight or have conditions like type 1 diabetes that could complicate the diet intervention.

Inclusion Criteria

I am 18 years old or older.
Be willing and able to adhere to study procedures, including use of a smartphone app
Own a smartphone
See 4 more

Exclusion Criteria

I am currently taking insulin.
I do not have conditions like type 1 diabetes, risk for low blood sugar, specific medication needs, pregnancy, breastfeeding, or a recent eating disorder that would prevent me from following the study's diet plan.
Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 12-week time-restricted eating intervention or receive general health education

12 weeks
Weekly educational tips (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Healthy lifestyle education
  • Time-restricted eating
Trial OverviewThe study tests if restricting eating to a 10-hour window each day for 12 weeks reduces fatigue in cancer survivors compared to those receiving general health education. Participants will be randomly assigned to either time-restricted eating or control group in equal numbers.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Time-restricted eatingExperimental Treatment2 Interventions
Participants will self-select a 10-hour window in which to consume all food and beverages (with the exception of black coffee and unsweetened tea in the mornings; water is okay at all times). Participants will also receive weekly tips to encourage a healthy lifestyle in cancer survivorship.
Group II: ControlExperimental Treatment1 Intervention
Participants will receive weekly tips to encourage healthy lifestyle behaviors in cancer survivorship.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, Baltimore

Lead Sponsor

Trials
729
Recruited
540,000+

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Trials
394
Recruited
404,000+

Findings from Research

Time-restricted eating (TRE) has shown promising therapeutic effects in rodent studies, particularly in relation to body weight and metabolic health, but results in humans are inconsistent due to varying study designs and populations.
This review highlights the need for more standardized research on TRE in humans to better understand its effects and interactions with circadian biology, as well as to identify gaps in current knowledge for future studies.
Complex physiology and clinical implications of time-restricted eating.Petersen, MC., Gallop, MR., Flores Ramos, S., et al.[2023]
Time-restricted eating (TRE) is a promising dietary approach that not only aids in weight management but also positively influences energy metabolism, gut microbiota, and overall homeostasis.
Chronodisruption, which occurs when our internal circadian rhythms are out of sync with external cues, is linked to serious health issues like metabolic disorders and cancer, highlighting the importance of aligning eating patterns with our biological clocks.
Time-restricted eating for chronodisruption-related chronic diseases.Cheng, WY., Desmet, L., Depoortere, I.[2023]
Modified alternate-day fasting (ADF) significantly reduces cell proliferation rates in various tissues, regardless of whether the diet is low-fat or high-fat, suggesting its potential as a cancer prevention strategy.
In a 4-week study with male mice, both ADF groups showed similar reductions in T-cell proliferation and decreased plasma insulin-like growth factor-1 levels, indicating that ADF can be effective across different dietary fat intakes.
Alternate-day fasting reduces global cell proliferation rates independently of dietary fat content in mice.Varady, KA., Roohk, DJ., Bruss, M., et al.[2009]

References

Complex physiology and clinical implications of time-restricted eating. [2023]
Time-restricted eating for chronodisruption-related chronic diseases. [2023]
Alternate-day fasting reduces global cell proliferation rates independently of dietary fat content in mice. [2009]
Time-Restricted Eating: Benefits, Mechanisms, and Challenges in Translation. [2021]
Time-restricted Eating to Address Cancer-related Fatigue among Cancer Survivors: A Single-arm Pilot Study. [2022]
Four Weeks of 16/8 Time Restrictive Feeding in Endurance Trained Male Runners Decreases Fat Mass, without Affecting Exercise Performance. [2021]
Effects of 4- and 6-h Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults with Obesity. [2022]
Metabolic Efficacy of Time-Restricted Eating in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2022]
Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study. [2022]